Aristroda (Aristada) is Alkermes’ long-acting injectable antipsychotic. The medicine is aripiprazole lauroxil, a prodrug of aripiprazole, used to treat schizophrenia in adults.
Key points:
- Formulation: long-acting intramuscular injection (administered in a muscle, usually the buttock or arm).
- Dosing/ initiation: There are different regimens. After an Aristada injection, you typically need oral aripiprazole for about 21 days to bridge until the injectable medicine reaches steady levels. There’s also a separate initiation option called Aristada Initio that uses a specific starting regimen. The exact dose and interval (e.g., how often you get the shot) are decided by your prescriber.
- Common side effects: injection-site reactions, akathisia (restlessness), weight changes, sleepiness, insomnia, nausea, restlessness, and potential metabolic effects (eg, changes in blood sugar, lipids). Like all antipsychotics, there is a risk of EPS, tardive dyskinesia, neuroleptic malignant syndrome, and changes in mood or suicidality risk.
- Interactions/ cautions: CYP2D6 and CYP3A4 inhibitors or inducers can affect aripiprazole levels. Not for people with hypersensitivity to aripiprazole lauroxil or aripiprazole. Discuss other meds and medical conditions with your clinician.
If you want, tell me what specifics you need (how it’s given, exact dosing options, side effects, or how Aristada compares with other antipsychotics), and I’ll tailor the info. If you’re considering Aristada for yourself or someone else, contact a clinician for personalized dosing and safety guidance.